(Q73307127)
Statements
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies (English)
B Movsas
C Scott
W Sause
R Byhardt
R Komaki
J Cox
D Johnson
C Lawton
A R Dar
T Wasserman
M Roach
J S Lee